Abu Dhabi has launched a new artificial intelligence initiative that aims to transform healthcare through the creation of digital human twins. The project is designed to improve early disease detection, support precision medicine, and help doctors develop more personalized treatments for patients.
The Abu Dhabi Biobank has partnered with BioTwin to introduce AI-powered Virtual Human Twin technology. The collaboration combines advanced artificial intelligence with large-scale biological, genomic, and clinical data to create digital models that closely represent an individual’s organs and biological systems.
Health officials believe the technology could play an important role in preventing disease, improving diagnosis, and accelerating medical research across the United Arab Emirates.
The partnership brings together BioTwin’s longitudinal biomarker platform with the Abu Dhabi Biobank’s extensive collection of biological samples, genomic information, and clinical records. Artificial intelligence will analyze these combined datasets to identify health risks, study complex diseases, and support faster clinical research.
Virtual Human Twin technology creates a digital representation of each patient using genetic information, biological data, and medical history. Unlike traditional health records, the digital model continuously updates as new health information becomes available.
The system is designed to process data from genomic sequencing, blood tests, wearable health devices, and Internet of Things sensors. By combining these data sources, artificial intelligence can monitor changes in a person’s health and estimate future disease risks before symptoms appear.
Medical experts say this technology could help healthcare providers identify diseases at much earlier stages. Earlier diagnosis often allows patients to receive treatment sooner, improving health outcomes and reducing the risk of serious complications.
The digital twins may also support precision medicine by helping doctors choose treatments that better match each patient’s genetic profile and medical condition. Instead of using the same treatment approach for every patient, physicians could tailor therapies based on detailed biological information.
Another important application involves virtual testing of medicines. Researchers hope digital twins will allow doctors to simulate different medications and dosage levels before treatment begins. This could reduce risks, improve treatment effectiveness, and shorten the time needed to select the most suitable therapy.
The technology may also assist surgeons during complex medical procedures. Digital models could help healthcare teams plan operations involving the heart, brain, and other critical organs by providing detailed virtual simulations before surgery takes place.
The agreement between Abu Dhabi Biobank and BioTwin was signed during the BIO International Convention 2026 in San Diego. The Abu Dhabi Biobank is a strategic initiative established through the Department of Health – Abu Dhabi and M42 to strengthen biomedical research and precision healthcare across the emirate.
Alongside the BioTwin partnership, Abu Dhabi signed additional agreements to expand its biotechnology and genomics programs.
One memorandum of understanding was signed with Arbor Biotechnologies to explore collaboration on gene-editing research and treatments for rare and inherited diseases. The partnership aims to advance scientific research while supporting future clinical development.
Another agreement was signed with Novartis Middle East FZ-LLC to strengthen genomics research, expand scientific expertise, and support the development of advanced therapies.
These partnerships reflect Abu Dhabi’s broader strategy to become a global center for healthcare innovation, biotechnology, and artificial intelligence. By combining advanced AI systems with one of the region’s growing genomic research programs, the emirate hopes to accelerate medical discoveries and improve patient care.
Health officials believe investments in digital health technologies, precision medicine, and biomedical research will help create a more advanced healthcare system while supporting economic diversification through knowledge-based industries. As artificial intelligence continues to reshape medicine worldwide, Abu Dhabi’s latest initiative places the emirate among the regions investing heavily in next-generation healthcare solutions.
